|
|
|
Volumn 22, Issue 3 SUPPL. 6, 1995, Pages 12-15
|
|
Paclitaxel in germ cell cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 HYDROPEROXYCYCLOPHOSPHAMIDE;
CIMETIDINE;
CISPLATIN;
DEXAMETHASONE;
DIPHENHYDRAMINE;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
PACLITAXEL;
PLATINUM;
ADOLESCENT;
ADULT;
ALLERGY;
ANTINEOPLASTIC ACTIVITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTINUOUS INFUSION;
DRUG CYTOTOXICITY;
DRUG POTENTIATION;
DRUG RESISTANCE;
FEMALE;
GERM CELL TUMOR;
HUMAN;
HUMAN CELL;
MALE;
NEUTROPENIA;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
TERATOCARCINOMA;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
CYCLOPHOSPHAMIDE;
DRUG RESISTANCE;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUG SYNERGISM;
FEMALE;
GERMINOMA;
HUMAN;
IFOSFAMIDE;
MALE;
MIDDLE AGE;
PACLITAXEL;
SUPPORT, U.S. GOV'T, P.H.S.;
TERATOCARCINOMA;
TUMOR CELLS, CULTURED;
|
|
EID: 0029041626
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (26)
|
|
References (0)
|
